Publication

Byline

Taiwan approves PharmaMar's treatment for small cell lung cancer as first-line maintenance therapy

Singapore, March 24 -- PharmaMar, a Spanish biopharmaceutical company with 40 years of experience, has announced that its treatment Zepzelca(R) (lurbinectedin), in combination with atezolizumab (Tecen... और पढ़ें


CHA Biotech and Novartis Korea partner to establish platform for biotech innovation

Singapore, March 24 -- CHA Biotech and Novartis Korea have signed a strategic Memorandum of Understanding (MoU) to establish a collaborative framework for bio open innovation based on the Cell Gene Bi... और पढ़ें